313988-70-4

Basic information

• Product Name: PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN)
• Synonyms: PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN);PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NPY (18-36) (HUMAN);H-ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ALA-AIB-ARG-GLN-ARG-TYR-NH2
• CAS NO: 313988-70-4
• Molecular Weight: 0
• Mol File: 313988-70-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN)(CAS DataBase Reference)
• NIST Chemistry Reference: PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN)(313988-70-4)
• EPA Substance Registry System: PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN)(313988-70-4)

Safety Data

• Hazardous Substances Data: 313988-70-4(Hazardous Substances Data)

Usage

Description

PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN) is a synthetic peptide engineered by combining the first 17 amino acids of pancreatic polypeptide with the 18th to 36th amino acids of neuropeptide Y, featuring alanine and aminoisobutyric acid substitutions at positions 31 and 32, respectively. This peptide is designed to emulate the biological functions of both pancreatic polypeptide and neuropeptide Y, offering a versatile tool for research and therapeutic interventions in various physiological and pathological conditions.

Uses

Used in Pharmaceutical Research:
PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN) is used as a research tool for understanding the roles of pancreatic polypeptide and neuropeptide Y in the human body. It aids in studying their interactions with receptors and signaling pathways, contributing to the development of novel therapeutic agents targeting these peptides.
Used in Drug Development:
This synthetic peptide is utilized in the development of drugs targeting gastrointestinal, metabolic, and central nervous system disorders. Its ability to modulate the functions of pancreatic polypeptide and neuropeptide Y makes it a promising candidate for treating conditions such as obesity, diabetes, and neurological disorders.
Used in Diagnostic Applications:
PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN) serves as a diagnostic marker in clinical settings. Its presence or levels in biological samples can indicate specific pathological conditions, aiding in the early detection and monitoring of diseases.
Used in Cosmetics Industry:
In the cosmetics industry, this peptide may be used as an active ingredient in anti-aging and skin health products. Its potential role in modulating skin cell functions and promoting tissue repair could contribute to the development of innovative skincare formulations.
Used in Nutraceuticals:
PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN) can be incorporated into nutraceutical products to support gastrointestinal health and improve metabolic functions. Its potential to modulate the activity of pancreatic polypeptide and neuropeptide Y may offer benefits in managing weight, digestion, and nutrient absorption.